PRELIMINARY COST-EFFECTIVENESS ANALYSIS OF PROTON BEAM THERAPY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA IN JAPAN

被引：0
|
作者：
Moriwaki, K. [1 ]
Katoh, N. [2 ]
Hayashi, H. [2 ]
Miyakoshi, T. [2 ]
Terashima, K. [3 ]
Murayama, S. [4 ]
Suzuki, M. [5 ]
Okumura, T. [6 ]
Araya, M. [7 ]
Hojo, H. [8 ]
Iwata, H. [9 ]
机构：
[1] Ritsumeikan Univ, Kyoto 26, Japan
[2] Hokkaido Univ Hosp, Sapporo, Hokkaido, Japan
[3] Hyogo Ion Beam Med Ctr, Tatsuno, Hyogo, Japan
[4] Shizuoka Canc Ctr, Shizuoka, Japan
[5] Southern Tohoku Proton Therapy Ctr, Fukushima, Japan
[6] Univ Tsukuba, Ibaraki, Japan
[7] Aizawa Hosp, Nagano, Japan
[8] Natl Canc Ctr Hosp East, Chiba, Japan
[9] Nagoya City Univ, West Med Ctr, Nagoya, Aichi, Japan
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE361
引用
收藏
页码：S406 / S406
页数：1
相关论文
共 50 条
  • [31] A preliminary study of hepatocellular carcinoma post proton beam therapy using MRI as an early prediction of treatment effectiveness
    Lin, Shen-Yen
    Chen, Chien-Ming
    Huang, Bing-Shen
    Lai, Ying-Chieh
    Pan, Kuang-Tse
    Lin, Shi-Ming
    Chu, Sung-Yu
    Tseng, Jeng-Hwei
    PLOS ONE, 2021, 16 (03):
  • [32] Current role of proton beam therapy in patients with hepatocellular carcinoma
    Yoo, Gyu Sang
    Yu, Jeong Il
    Park, Hee Chul
    INTERNATIONAL JOURNAL OF GASTROINTESTINAL INTERVENTION, 2021, 10 (04): : 175 - 182
  • [33] Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis
    Hata, Masaharu
    Tokuuye, Koichi
    Sugahara, Shinji
    Fukumitsu, Nobuyoshi
    Hashimoto, Takayuki
    Ohnishi, Kayoko
    Nemoto, Keiko
    Ohara, Kiyoshi
    Matsuzaki, Yasushi
    Akine, Yasuyuki
    STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 (12) : 713 - 720
  • [34] COST-EFFECTIVENESS ANALYSIS OF REGORAFENIB AS A SECOND-LINE THERAPY IN THE TREATMENT OF HEPATOCELLULAR CARCINOMA IN CHINA
    Xiao, D.
    Zhu, S.
    Sun, W.
    Xuan, J.
    VALUE IN HEALTH, 2019, 22 : S187 - S188
  • [35] Proton Beam Therapy for Hepatocellular Carcinoma: Multicenter Prospective Registry Study in Japan
    Mizumoto, Masashi
    Ogino, Hiroyuki
    Okumura, Toshiyuki
    Terashima, Kazuki
    Murakami, Masao
    Ogino, Takashi
    Tamamura, Hiroyasu
    Akimoto, Tetsuo
    Waki, Takahiro
    Katoh, Norio
    Araya, Masayuki
    Onoe, Tsuyoshi
    Takagi, Masaru
    Iwata, Hiromitsu
    Numajiri, Haruko
    Okimoto, Tomoaki
    Uchinami, Yusuke
    Maruo, Kazushi
    Shibuya, Kei
    Sakurai, Hideyuki
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (03): : 725 - 733
  • [36] Cost-effectiveness analysis of personalised versus standard dosimetry for selective internal radiation therapy with TheraSphere in patients with hepatocellular carcinoma
    Rognoni, Carla
    Barcellona, Maria Rosa
    Bargellini, Irene
    Bavetta, Maria Grazia
    Bello, Marilena
    Brunetto, Maurizia
    Carucci, Patrizia
    Cioni, Roberto
    Crocetti, Laura
    D'Amato, Fabio
    D'Amico, Mario
    Deagostini, Simona
    Deandreis, Desiree
    De Simone, Paolo
    Doriguzzi, Andrea
    Finessi, Monica
    Fonio, Paolo
    Grimaldi, Serena
    Ialuna, Salvatore
    Lagattuta, Fabio
    Masi, Gianluca
    Moreci, Antonio
    Scalisi, Daniele
    Virdone, Roberto
    Tarricone, Rosanna
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [37] COST-EFFECTIVENESS OF DIFFERENT TREATMENTS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA: A RETROSPECTIVE STUDY
    Chu, P. C.
    Chen, C. H.
    Wang, J. D.
    Hwang, J. S.
    VALUE IN HEALTH, 2009, 12 (03) : A45 - A45
  • [38] Cost-effectiveness of a precision hepatocellular carcinoma surveillance strategy in patients with cirrhosis
    Kao, Szu-Yu Zoe
    Sangha, Kinpritma
    Fujiwara, Naoto
    Hoshida, Yujin
    Parikh, Neehar D.
    Singal, Amit G.
    ECLINICALMEDICINE, 2024, 75
  • [39] Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma
    Camma, Calogero
    Cabibbo, Giuseppe
    Petta, Salvatore
    Enea, Marco
    Iavarone, Massimo
    Grieco, Antonio
    Gasbarrini, Antonio
    Villa, Erica
    Zavaglia, Claudio
    Bruno, Raffaele
    Colombo, Massimo
    Craxi, Antonio
    HEPATOLOGY, 2013, 57 (03) : 1046 - 1054
  • [40] Lenvatinib versus sorafenib for unresectable hepatocellular carcinoma: a cost-effectiveness analysis
    Cai, Hongfu
    Zhang, Longfeng
    Li, Na
    Zheng, Bin
    Liu, Maobai
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (08) : 553 - 562
12345